Literature DB >> 34742406

Unsymmetrical, monocarboxyalkyl meso-arylporphyrins in the photokilling of breast cancer cells using permethyl-β-cyclodextrin as sequestrant and cell uptake modulator.

Stylianos Panagiotakis1, Barbara Mavroidi2, Alexandros Athanasopoulos3, Georgios Charalambidis4, Athanassios G Coutsolelos5, Maria Paravatou-Petsotas6, Maria Pelecanou7, Irene M Mavridis8, Konstantina Yannakopoulou9.   

Abstract

In the search for photosensitizers with chemical handles to facilitate their integration into complex drug delivery nanosystems, new, unsymmetrically substituted, water insoluble meso-tetraphenylporphyrin and meso-tetra(m-hydroxyphenyl)porphyrin derivatives bearing one carboxyalkyl side chain were synthesized. Permethyl-β-cyclodextrin (pMβCD) was their ideal monomerizing host and highly efficient shuttle to transfer them into water. New assembly modes of the extremely stable (Kbinding > 1012 M-2) 2:1 complexes were identified. The complexes are photostable and do not disassemble in FBS-containing cell culture media for 24 h. Incubation of breast cancer MCF-7 cells with the complexes results in intense intracellular fluorescence, strongly enhanced in the endoplasmic reticulum (ER), high photokilling efficiency (~90%) and low dark toxicity. pMβCD stands out as a very capable molecular isolator of mono-carboxyalkyl-arylporphyrins that increases uptake and modulates their localization in the cells. The most efficient porphyrins are envisaged as suitable photosensitizers that can be linked to biocompatible drug carriers for photo- and chemo-therapy applications.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Endoplasmic reticulum (ER); Inclusion complexes; Monocarboxyalkyl-porphyrins; Permethyl-β-cyclodextrin; Photokilling

Mesh:

Substances:

Year:  2021        PMID: 34742406     DOI: 10.1016/j.carbpol.2021.118666

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  1 in total

Review 1.  An Updated Overview of Cyclodextrin-Based Drug Delivery Systems for Cancer Therapy.

Authors:  Dan Nicolae Păduraru; Adelina-Gabriela Niculescu; Alexandra Bolocan; Octavian Andronic; Alexandru Mihai Grumezescu; Rodica Bîrlă
Journal:  Pharmaceutics       Date:  2022-08-22       Impact factor: 6.525

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.